hypereosinophilic syndromes

Nucala works in rare inflammatory disease, says GSK
PM Live
Wed, 11/13/19 - 09:55 am
GSK
clinical trials
Nucala
hypereosinophilic syndromes
HES
Knopp Biosciences' Dexpramipexole Meets Primary Endpoints in Phase 2 Trial Results in Hypereosinophilic Syndromes (HES)
CP Wire
Thu, 05/10/18 - 10:08 am
Knopp Biosciences
dexpramipexole
hypereosinophilic syndromes
Knopp Biosciences' Dexpramipexole Meets Primary Endpoints in Phase 2 Trial Results in Hypereosinophilic Syndromes (HES)
Thu, 05/10/18 - 10:09 am
Knopp Biosciences
dexpramipexole
hypereosinophilic syndromes